Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

Clinical trial NCT02169466 · COMPLETED

Trial details

NCT number: NCT02169466
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease (PD)

Start date: 2009-01-01
Primary completion: 2009-05-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.